CN1308009C - Health care product having blood pressure regulating function - Google Patents
Health care product having blood pressure regulating function Download PDFInfo
- Publication number
- CN1308009C CN1308009C CNB2005100642254A CN200510064225A CN1308009C CN 1308009 C CN1308009 C CN 1308009C CN B2005100642254 A CNB2005100642254 A CN B2005100642254A CN 200510064225 A CN200510064225 A CN 200510064225A CN 1308009 C CN1308009 C CN 1308009C
- Authority
- CN
- China
- Prior art keywords
- present
- blood pressure
- health
- pressure regulation
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000036541 health Effects 0.000 title claims description 13
- 230000036772 blood pressure Effects 0.000 title description 3
- 230000001105 regulatory effect Effects 0.000 title 1
- 230000029865 regulation of blood pressure Effects 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 239000002775 capsule Substances 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241001251068 Formica fusca Species 0.000 claims description 12
- 241001620634 Roger Species 0.000 claims description 9
- 239000003814 drug Substances 0.000 abstract description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract description 8
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 abstract description 7
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 abstract description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract description 4
- 235000019253 formic acid Nutrition 0.000 abstract description 4
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 241000257303 Hymenoptera Species 0.000 abstract 3
- 208000007530 Essential hypertension Diseases 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 235000013402 health food Nutrition 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 5
- 150000002213 flavones Chemical class 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 241000219780 Pueraria Species 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- YSCJAYPKBYRXEZ-HZPINHDXSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YSCJAYPKBYRXEZ-HZPINHDXSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000237986 Melia azadirachta Species 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- -1 triterpenoid compound Chemical class 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention discloses a health-care product with the function of blood pressure regulation, which comprises active ingredients prepared from the following raw material by weight parts: 0.1 to 10 parts of eucommia bark, 0.1 to 10 parts of kudzuvine root and 1 part of ants, wherein the ants needed in the present invention are quasi black multiple lunge ants. An optimal preparation of the present invention is a granule capsule. Detection shows that every 100g of the present invention contains 1.58 mg of formic acid and 5.0g of puerarin. The health-care product with the function of blood pressure regulation is suitable for people with essential hypertension and is not suitable for pregnant women, women in lactation, infants, children and allergic people of foreign protein. The present invention is prepared by means of a conventional method for preparing a traditional Chinese medicine granule capsule. Each capsule contains 0.4g of medicine, a patient takes the medicine for 2 to 3 granules each time and three times a day. The present invention is health-care food only and cannot replace medicine.
Description
[technical field]
The present invention relates to a kind of health food, specifically, relate to a kind of health product with blood pressure regulation function.
[background technology]
Now, people's life stress generally strengthens, and rhythm of life is accelerated, and is increasingly competitive, and the hyperpietic is more and more, and the blood pressure of indication is the side pressure that blood produces blood vessel wall when flowing in blood vessel usually.Blood viscosity is too high in arteries, and the resistance of blood flow will increase, and causes blood flow slow excessively, makes lipid material produce deposition on blood vessel wall, brings out atherosclerosis, and blood vessel is narrowed down, and sclerosis of blood vessels causes hypertension.
China's tradition is paid attention to integration of edible and medicinal herbs, and the health food of integration of edible and medicinal herbs is subjected to modern's favor more and more.How to consumers in general provide a kind of natural Chinese medicines preparation, without any toxic and side effects, the health food of the health care with blood pressure regulation of integration of edible and medicinal herbs becomes the new problem of current medical science.
[summary of the invention]
The technical issues that need to address of the present invention just are to provide a kind of health food of pure Chinese medicinal preparation, and it has the health care of blood pressure regulation.
For addressing the above problem, the present invention adopts following technical scheme:
The present invention has the health product of blood pressure regulation function, and by weight ratio, the preparation raw material of the active component that it is contained comprises: Cortex Eucommiae 0.1-10 part, Radix Puerariae 0.1-10 part, 1 part of Formica fusca.
Preferably, the health product that the present invention has a blood pressure regulation function by weight ratio, the preparation raw material of the active component that it is contained comprises: Cortex Eucommiae 0.1-1 part, Radix Puerariae 0.1-1 part, 1 part of Formica fusca.
Or by weight ratio, the preparation raw material of the active component that it is contained comprises: 0.5 part of the Cortex Eucommiae, 0.5 part of Radix Puerariae, 1 part of Formica fusca.
Or by weight ratio, the preparation raw material of the active component that it is contained comprises: Cortex Eucommiae 1-10 part, Radix Puerariae 1-10 part, 1 part of Formica fusca.
Or by weight ratio, the preparation raw material of the active component that it is contained comprises: 1 part of the Cortex Eucommiae, 1 part of Radix Puerariae, 1 part of Formica fusca.
Or by weight ratio, the preparation raw material of the active component that it is contained comprises: 5 parts of the Cortexs Eucommiae, 5 parts of Radix Puerariaes, 1 part of Formica fusca.
Preferably, Formica fusca of the present invention is a Polyhachis vicina Roger.
Preferably, the present invention have the blood pressure regulation function health product it be the granule capsule.
The present invention is based on understanding and the Therapeutic Principle of motherland's medical science, draw the modern study achievement, from Chinese medicine, filter out the natural plant of health care, press the tcm theory prescription with blood pressure regulation to health food.
Among the present invention, the Cortex Eucommiae, have another name called think celestial, think second month in a season, kapok, a gross weight, red neem bark.It is the bark of cutting off on the deciduous tree gutta-percha tree, a kind of rare medicinal herbs that is processed into by certain method and specification.
Cortex Eucommiae medical value height, the prescription broad continues the high pressure-reducing function except that having, can also be antiabortive, invigorating the liver and kidney, bone and muscle strengthening; Take the Cortex Eucommiae and can control diseases such as ache of the spinal column, dribbling urination, uncontrolled urination are itched, the bob of vaginal bleeding during pregnancy desire.Through the clinical diagnosis assay certificate, this medicine is the most effective with treatment early high blood pressure and poliomyelitis sequela especially.
Among the present invention, Radix Puerariae is the root of leguminous plant Pueraria lobota Pueraria lobata (Willd.) Ohwi.The composition that mainly contains in its root: 1. many kinds of isoflavone: daidzin, daidzein, puerarin etc.; 2. Radix Puerariae glycoside A, B, C; 3. triterpenes: mainly with 7 kinds of novel oleanane type alcohol compounds of Pueraria lobota soap alcohol A, B, C name; 4. alkaloids.
Radix Puerariae water decoction, pure extractum, total flavones, puerarin all have the effect of tangible expansion coronary vasodilator.Normal quiet notes of Canis familiaris L. 30mg/kg total flavones, its coronary flow increases by 40%, vascular resistance reduction by 29%, and this effect increases with the increase of dosage; Total flavones also can resist the Acute Myocardial Ischemia in Rats that pituitrin causes.The effect of puerarin is better than total flavones.From the quiet notes puerarin of right ventricle's bypass 15～20mg/kg/min of acute myocardial ischemia Canis familiaris L., 15min can make and enter the increase of ischemic region arteria coronaria side shoot blood flow continuously, and non-ischemic region coronary flow also increases.After the reserpine administration, total flavones and puerarin still keep the effect of coronary circulation, show that its effect is the direct relexation to vascular smooth muscle.
Among the present invention, Formica fusca has another name called ant, and medicinal name is called " XUANJU ", belongs to holometabolous insecticide.The Formica fusca nature and flavor are salty, flat, toxic.Medical value is higher, and the medical value of Formica fusca is higher, has rheumatism, antiinflammatory, sterilization, antibacterial, anticancer, antiallergic, hepatoprotective, relievings asthma, eases pain, function such as calmness, tonifying YANG, YIN nourishing, detoxifcation.Rheumatoid arthritis, rheumatic arthritis, malignant tumor, chronic hepatitis, pulmonary tuberculosis, sexual impotence, post disease alopecia, neurosis etc. all there is good medical effect.
The preferred Polyhachis vicina Roger of the present invention is as traditional methods to keep in good health's resource, and literature record has the history in more than 3,000 year.Polyhachis vicina Roger contains rich in protein, and its content is up to 40%-55%, and minority can reach more than 67%.In its contained 19 seed amino acids, have 8 kinds be essential amino acid promptly: threonine, phenylalanine, valine, isoleucine, leucine, sour jujube propylhomoserin, methionine, tryptophan etc.And contain 28 kinds of trace element such as vitamin A, vitamin B1, B2, B12 and C, D, E and calcium, ferrum, chromium, magnesium, zinc, iodine, selenium, wherein the content with zinc is maximum, reaches every kilogram and contains zinc 230mg-280mg.The most specifically Polyhachis vicina Roger contains multiple enzyme and coenzyme, cursive script formic acid, black same clan chemical compound, triterpenoid compound, formic acid, contains a large amount of high energy phosphide ATP simultaneously, the Compendium of Material Medica record; Polyhachis vicina Roger " strengthening vital QI to eliminate pathogenic factors, kidney-tonifying health-care, activating blood circulation to dissipate blood stasis, life lengthening.The physical strength profiting of food, damp color." " Chinese medicine dictionary " record, Polyhachis vicina Roger is to the odd effect of defying age.
The major function of Polyhachis vicina Roger has:
1, joint disease: rheumatoid, rheumatic arthritis, scapulohumeral periarthritis, lumbago and skelalgia.
2, cardiovascular and cerebrovascular disease: coronary heart disease, cerebral infarction sequela, angina pectoris, myocarditis.
3, diseases of urinary system: nephritis, sexual impotence, premature ejaculation, hyposexuality.
4, digestive system disease: gastritis, dyspepsia, cholecystitis, hepatitis, hepatic ascites, liver cirrhosis.
5, nervous system disease: neurasthenia, autonomic nervous dysfunction, insomnia, headache.
6, other diseases: diabetes, lupus erythematosus, scleroderma, teen-ager leukotrichia, loss of tooth, cancer postoperative.
Above-mentioned prescription of the present invention can directly be pulverized or be refining as its active component through the extraction of the conventional extractive technique in this area such as decoction and alcohol sedimentation technique or ethanol extract from water precipitation.Described active component can be made various pharmaceutical formulations such as powder, tablet, oral liquid, granule, injection, capsule or the like with the combination of pharmaceutically acceptable carrier or excipient.Wherein said pharmaceutically acceptable carrier or excipient are selected according to different dosage forms.These used carriers or excipient can determine for the those of ordinary skill of pharmaceutical field.
Most preferred dosage form of the present invention is a kind of granule capsule, after testing, the every 100g of the present invention contains: formic acid 1.58mg, and puerarin 5.0g, the health product that the present invention has the blood pressure regulation function have the function of blood pressure regulation, be suitable for the higher person of blood pressure, be unwell to anemia of pregnant woman and women breast-feeding their children, infant, children and foreign protein allergy sufferers, Chinese medicinal granule agent capsules method preparation routinely, every capsules content of dispersion is 0.4g, usage and dosage: a 2-3 grain, every day three times.The present invention is a kind of health food, can not alternative medicine.
[specific embodiment]
Now the present invention is further described as follows in conjunction with specific embodiments:
1, listed weight proportion takes by weighing raw material required for the present invention in the according to the form below, unit: kg
| The Cortex Eucommiae | Radix Puerariae | Polyhachis vicina Roger | |
| Embodiment 1 | 0.1 | 0.1 | 1 |
| Embodiment 2 | 0.5 | 0.5 | 1 |
| Embodiment 3 | 1 | 1 | 1 |
| Embodiment 4 | 5 | 5 | 1 |
| Embodiment 5 | 10 | 10 | 1 |
2, preparation embodiment
By proportioning raw materials among each embodiment in the last table, be prepared into the granule capsule according to the preparation method of conventional granulates agent capsules and remember that ant power is refreshing according to glad capsule.
Claims (3)
1, a kind of health product with blood pressure regulation function is characterized in that the preparation parts by weight of raw materials proportioning of the active component that it is contained is: 0.5 part of the Cortex Eucommiae, 0.5 part of Radix Puerariae, 1 part of Formica fusca.
2, the health product with blood pressure regulation function as claimed in claim 1 is characterized in that described Formica fusca is a Polyhachis vicina Roger.
3, the health product with blood pressure regulation function as claimed in claim 1 or 2 is characterized in that it is the granule capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100642254A CN1308009C (en) | 2005-04-11 | 2005-04-11 | Health care product having blood pressure regulating function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100642254A CN1308009C (en) | 2005-04-11 | 2005-04-11 | Health care product having blood pressure regulating function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1686395A CN1686395A (en) | 2005-10-26 |
| CN1308009C true CN1308009C (en) | 2007-04-04 |
Family
ID=35304437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100642254A Expired - Fee Related CN1308009C (en) | 2005-04-11 | 2005-04-11 | Health care product having blood pressure regulating function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1308009C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102172385B (en) * | 2011-01-12 | 2016-02-24 | 涂传荣 | A kind of Chinese medicine preparation with enhancing immunity, blood sugar lowering and effect for reducing blood fat |
| CN103461880A (en) * | 2013-08-13 | 2013-12-25 | 当涂县瑞龙果树种植专业合作社 | Blood pressure-lowering pumpkin slice |
| CN106166169A (en) * | 2016-08-17 | 2016-11-30 | 崔明华 | The medicine of a kind of two-ways regulation blood pressure and production method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1106674A (en) * | 1994-10-13 | 1995-08-16 | 汪志伟 | Traditional Chinese medicine for curing paralysis |
| CN1433787A (en) * | 2002-01-19 | 2003-08-06 | 马献山 | Oral and external medicine for dispelling wind-damp and stopping arthralgia |
-
2005
- 2005-04-11 CN CNB2005100642254A patent/CN1308009C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1106674A (en) * | 1994-10-13 | 1995-08-16 | 汪志伟 | Traditional Chinese medicine for curing paralysis |
| CN1433787A (en) * | 2002-01-19 | 2003-08-06 | 马献山 | Oral and external medicine for dispelling wind-damp and stopping arthralgia |
Non-Patent Citations (3)
| Title |
|---|
| 益本昌药酒的研制临床应用与微量元素测定 戚建国等，广东微量元素科学，第6卷第5期 1999 * |
| 蚂蚁制剂药理研究的新进展 何颖等，时珍国医国药，第14卷第2期 2003 * |
| 蚂蚁制剂药理研究的新进展 何颖等，时珍国医国药，第14卷第2期 2003;益本昌药酒的研制临床应用与微量元素测定 戚建国等，广东微量元素科学，第6卷第5期 1999 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1686395A (en) | 2005-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103877263B (en) | A kind of antifatigue health preparation of the compound Chinese medicine such as red ginseng, maca, green-tea extract (theanine) | |
| CN102630790B (en) | Tartary buckwheat tea prepared by Ginkgo biloba leaf and preparation process thereof | |
| CN100379439C (en) | Health product for enhancing immunity and soothing the nerves | |
| CN102920806B (en) | Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea | |
| CN107006856A (en) | One kind enhancing endurance, raising anti anoxia tolerance nutritional agents and preparation method thereof | |
| CN103479754B (en) | Hypotensive drug and preparation method thereof | |
| CN1308009C (en) | Health care product having blood pressure regulating function | |
| CN105287780A (en) | Plant beverage and preparation method thereof | |
| CN1060028C (en) | Health food macte from cereal, vegetable and fruit | |
| CN103100028A (en) | Soft capsule favorable for reducing alcoholic liver injury and preparation method thereof | |
| CN1314423C (en) | Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases | |
| CN102228596B (en) | Pharmaceutical composition and preparation and applications thereof in treating coronary heart disease and angina pectoris | |
| CN1799582A (en) | Blood sugar- and blood pressure-lowering medicine | |
| CN109528827B (en) | Pharmaceutical composition and preparation for promoting blood circulation, removing blood stasis and reducing blood fat and preparation method thereof | |
| CN1279949C (en) | Chinese medicine for fat reducing and long life | |
| CN1321484A (en) | Medicine for curing coronary heart disease with hypertension and its preparation process | |
| CN1686396A (en) | Health care product having anoxia tolerance function | |
| CN101172155A (en) | New formulation of pulse-activating gallbladder-warming decoction and production method thereof | |
| CN113456778A (en) | Composition for improving energy and preparation method thereof | |
| CN106177634A (en) | A kind of weight-reducing compound preparation and preparation method thereof | |
| CN1686397A (en) | Health care food possessing liver boosting function | |
| CN1308016C (en) | Enriching supplementation wine | |
| CN114515009B (en) | Composition with weight-losing and lipid-lowering effects and application thereof | |
| CN101073409A (en) | Multipurpose medicinal edible food | |
| CN1810268A (en) | Apoplexy treating medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |